CD147 is raised in serum EVs from CRC patients—this rise is detectable earlier than current biomarkers used for CRC diagnosis such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19‐9 (CA19‐9). Here, CEACAM5 is linked to colorectal carcinoma.